Compare GSK plc (GSK) vs Western Digital Corp (WDC) Price & Performance

GSK's stock trades at $51.25, down 1.99% on the day, with a bearish technical signal from moving averages. Fundamentally, the company shows strong profitability with a 17.78% net margin and 36.42% ROE, supported by a consistent earnings beat history. Recent positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline progress. Valuation appears reasonable with a P/E of 13.71 and EV/EBITDA of 9.16.

The outlook balances a solid core business and promising oncology pipeline against a mixed analyst consensus and near-term cash flow pressures. Key opportunities lie in execution of new drug launches and the upcoming CEO strategy update, while risks include clinical trial setbacks, competitive pressures, and integration of potential acquisitions like Nuvalent.

Western Digital (WDC) trades at $563.32, up 1.4% over 24 hours, with strong recent earnings beats and a bullish analyst consensus. The stock shows neutral technical signals but benefits from robust profitability metrics, including a 55.07% net income margin and 37.73% ROE. Recent news highlights volatility in memory stocks, but AI-driven storage demand and HAMR technology advancements provide growth catalysts.

Outlook remains positive with a $619.07 consensus price target, though risks include competitive pressures from new market entrants and sector volatility. Earnings growth and margin expansion are key drivers, but investors should monitor execution against rising debt levels and industry cyclicality.